They also found that fat cells are capable of driving metabolic reprogramming of metastatic prostate tumors through oxygen-independent mechanism of activating hypoxia-inducible factor 1 alpha signaling that can be reversed by hypoxia-inducible factor 1 alpha downregulation. Here, HIF1A is linked to prostate neoplasm.